Sex differences for cognitive decline in progressive supranuclear palsy.

[1]  A. Moè,et al.  Sex/Gender Differences in Verbal Fluency and Verbal-Episodic Memory: A Meta-Analysis , 2022, Perspectives on psychological science : a journal of the Association for Psychological Science.

[2]  E. Moro,et al.  Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies , 2022, Movement disorders : official journal of the Movement Disorder Society.

[3]  J. Rowe,et al.  Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants , 2021, Brain communications.

[4]  A. Kishore,et al.  Gender differences in progressive supranuclear palsy , 2021, Acta Neurologica Belgica.

[5]  B. Ward,et al.  Prevalence of Multiple Chronic Conditions Among US Adults, 2018 , 2020, Preventing chronic disease.

[6]  Julie A. Harris,et al.  A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease , 2020, Science Translational Medicine.

[7]  C. Troakes,et al.  Copathology in Progressive Supranuclear Palsy: Does It Matter? , 2020, Movement disorders : official journal of the Movement Disorder Society.

[8]  Sterling C. Johnson,et al.  Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau , 2020, Brain communications.

[9]  John L. Robinson,et al.  Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD. , 2019, Journal of neuropathology and experimental neurology.

[10]  J. Cummings,et al.  Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume , 2019, Alzheimer's Research & Therapy.

[11]  B. Benayoun,et al.  Widespread sex dimorphism in aging and age-related diseases , 2019, Human Genetics.

[12]  E. Tolosa,et al.  Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability. , 2019, Parkinsonism & related disorders.

[13]  F. Blandini,et al.  Parkinson’s Disease in Women and Men: What’s the Difference? , 2019, Journal of Parkinson's disease.

[14]  Keith A. Johnson,et al.  Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults , 2019, JAMA neurology.

[15]  David A. Bennett,et al.  Sexual dimorphism in predisposition to Alzheimer's disease , 2018, Neurobiology of Aging.

[16]  M. Albert,et al.  Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. , 2018, Parkinsonism & related disorders.

[17]  Per B. Brockhoff,et al.  lmerTest Package: Tests in Linear Mixed Effects Models , 2017 .

[18]  B. Borroni,et al.  Natural history and predictors of survival in progressive supranuclear palsy , 2017, Journal of the Neurological Sciences.

[19]  D. Dickson,et al.  Cognitive impairment in progressive supranuclear palsy is associated with tau burden , 2017, Movement disorders : official journal of the Movement Disorder Society.

[20]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[21]  P. Leigh,et al.  Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[22]  C. Pike.  Sex and the development of Alzheimer's disease , 2017, Journal of neuroscience research.

[23]  M. Hallett,et al.  Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants , 2016, Acta neurologica Scandinavica.

[24]  T. Gale,et al.  Sex differences in cognitive impairment in Alzheimer's disease. , 2016, World journal of psychiatry.

[25]  Susan M Resnick,et al.  Sex differences in cognitive trajectories in clinically normal older adults. , 2016, Psychology and aging.

[26]  G. Gillies,et al.  Sex differences in Parkinson’s disease , 2014, Frontiers in Neuroendocrinology.

[27]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[28]  E. Tolosa,et al.  A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy , 2014, Movement disorders : official journal of the Movement Disorder Society.

[29]  T. Ferman,et al.  Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. , 2013, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[30]  L. Broestl,et al.  Sex and gonadal hormones in mouse models of Alzheimer’s disease: what is relevant to the human condition? , 2012, Biology of Sex Differences.

[31]  Emily W. Gower,et al.  Sex differences in cognition in healthy elderly individuals , 2012, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

[32]  Reisa A. Sperling,et al.  Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease , 2011, Alzheimer's & Dementia.

[33]  A. Tröster,et al.  Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices. , 2007, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[34]  L. Golbe,et al.  A clinical rating scale for progressive supranuclear palsy. , 2007, Brain : a journal of neurology.

[35]  A. Herlitz,et al.  Stability of sex differences in cognition in advanced old age: the role of education and attrition. , 2006, The journals of gerontology. Series B, Psychological sciences and social sciences.

[36]  R. Uitti,et al.  Progressive supranuclear palsy: Phenotypic sex differences in a clinical cohort , 2006, Movement disorders : official journal of the Movement Disorder Society.

[37]  W. M. van der Flier,et al.  Epidemiology and risk factors of dementia , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  E. Gordon,et al.  Category and letter verbal fluency across the adult lifespan: relationship to EEG theta power. , 2005, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[39]  P. Nichelli,et al.  The Frontal Assessment Battery (FAB): normative values in an Italian population sample , 2005, Neurological Sciences.

[40]  A. Lees,et al.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.

[41]  P. Ricciardelli,et al.  Monitoring cognitive changes: psychometric properties of six cognitive tests. , 2004, The British journal of clinical psychology.

[42]  I Litvan,et al.  Progressive supranuclear palsy , 1998, Neurology.

[43]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[44]  M. Linn,et al.  Gender differences in verbal ability: A meta-analysis. , 1988 .

[45]  M. Cesari,et al.  Sex and gender differences in the treatment of Alzheimer's disease: A systematic review of randomized controlled trials , 2017, Pharmacological research.